Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

IBRX

ImmunityBio, Inc.

CIK 0001326110 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$8.87
↑ 0.07 (0.80%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership, Technicals, Options

Key stats

Market Cap
$9.29B
P/E Ratio
-10.87
EPS
-0.38
Dividend Yield
Not covered
52W Position
66%
Beta
1.71

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-10.69
P/S
65.90
EV/Revenue
64.45
ROE
98.3%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 66%
$1.95$12.43

Latest Financials

2025-12-31 FY
Revenue
$113.29M
Net Income
-$351.40M
Total Assets
$501.90M
Free Cash Flow
-$308.78M

Recent news